Background: It is unknown why human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) cause severe respiratory infection in children, particularly in premature infants. Our aim was to investigate if there are defective airway antiviral responses to these viruses in young children with history of prematurity. Methods: Nasal airway secretions were collected from 140 children ≤3 y old without detectable virus (n = 80) or with PCRconfirmed HMPV or RSV infection (n = 60). Nasal protein levels of IFNγ, CCL5/RANTES, IL-10, IL-4, and IL-17 were determined using a multiplex magnetic bead immunoassay. results: Full-term children with HMPV and RSV infection had increased levels of nasal airway IFNγ, CCL5, and IL-10 along with an elevation in Th1 (IFNγ)/Th2 (IL-4) ratios, which is expected during antiviral responses. In contrast, HMPV-infected premature children (< 32 wk gestation) did not exhibit increased Th1/ Th2 ratios or elevated nasal airway secretion of IFNγ, CCL5, and IL-10 relative to uninfected controls. conclusion: Our study is the first to demonstrate that premature infants have defective IFNγ, CCL5/RANTES, and IL-10 airway responses during HMPV infection and provides novel insights about the potential reason why HMPV causes severe respiratory disease in children with history of prematurity.
cause more severe disease in young individuals with history of prematurity (gestational age <32 wk) (2) (3) (4) (5) . Indeed, RSV is associated with severe respiratory infections in premature babies, and prophylaxis with a humanized monoclonal antibody against the fusion (F) protein of RSV (Palimizumab) is recommended for them during their first RSV seasons (11) . There are also reports describing severe HMPV infections in young children born extremely premature (5) . Importantly, the nature of the human antiviral airway immune responses to RSV and HMPV infections in premature children has been remarkably understudied.
Previous studies have established that RSV and HMPV elicit antiviral immune responses consisting of virally-induced production of IFNγ, CCL5//RANTES, and IL-10 (12). Interestingly, despite the clinical and genetic similarities between these respiratory viruses, HMPV infections are characterized by attenuated IFN-γ, IL-10, and CCL5/RANTES responses relative to RSV (12) . Although the mechanism by which HMPV alters IFN-mediated responses is not completely understood, there is in vitro evidence demonstrating that HMPV alters IFN-mediated activation of interferon-stimulated response elements, interferon-stimulated genes and STAT 1 downstream signaling (13, 14) . It is however unclear if this HMPV-induced defective antiviral immunity is present during naturally occurring infections in humans, particularly in young children with history of prematurity in which HMPV is known to cause more severe disease. Accordingly, the overall goal of this study was to investigate if infants and young children (<3 y of age) born premature (<32 wk gestation) exhibit impaired airway secretion of IFNγ, CCL5//RANTES, and IL-10 during naturally occurring HMPV infections.
RESULTS

Baseline Characteristics
One hundred and fourty children were included in this study. The total study population was subdivided by viral-specific Analysis of nasal IFNγ protein levels showed that young children born full term with RSV or HMPV infection had higher mean nasal IFNγ responses compared to controls without an identifiable virus (RSV: 0.80 ± 0.15 pg/ml vs. control: 0.29 ± 0.09 pg/ml; P < 0.05; HMPV: 0.88 ± 0.13 pg/ml vs. control: 0.29 ± 0.09 pg/ml; P < 0.05; Figure 1) . Interestingly, subjects with history of prematurity (GA < 32 wk) and RSV infection had higher mean nasal levels of IFNγ than premature children (RSV: 0.75 ± 0.12 pg/ml vs. control: 0.32 ± 0.07 pg/ml; P < 0.05; Figure 1a) , however, children born premature with HMPV infection did not exhibit significant differences in the IFNγ nasal levels compared to controls (HMPV: 0.11 ± 0.29 pg/ml vs. control: 0.32 ± 0.07 pg/ml; P = 0.29; Figure 1b) . Collectively, these results suggest that there is a defective antiviral IFNγ airway response in premature children with HMPV.
Premature Infants Have Deficient CCL5/RANTES and IL-10 Airway Responses During HMPV Infection
Airway secretion of CCL5/RANTES and IL-10 has been identified in vitro and in vivo during infection with paramixoviruses (8, 12, 15, 16) . Accordingly, to further investigate the antiviral responses to RSV and HMPV, we measured nasal protein levels of CCL5/RANTES and IL-10 in full-term and premature children. As shown in Figure 1 , relative to controls, full-term subjects with RSV had higher nasal protein levels of CCL5/ RANTES (RSV: 1.72 ± 0.18 pg/ml vs. control: 0.54 ± 0.12 pg/ml; P < 0.05; Figure 1a ) and IL-10 (RSV: 1.2 ± 0.14 pg/ml vs. control: 0.4 ± 0.13 pg/ml; P < 0.05; Figure 1a) . Full-term children with HMPV infection also exhibited increased nasal protein levels of CCL5/RANTES (HMPV: 1.76 ± 0.12 vs. 0.54 ± 0.06 pg/ml; P < 0.05; Figure 1b ) and IL-10 (HMPV: 1.13 ± 0.16 vs. 0.4 ± 0.13 pg/ml; P < 0.05; Figure 3b ) compared to controls.
Interestingly, although premature children with RSV infection also had higher protein levels of CCL5/RANTES (RSV: 1.61 ± 0.19 vs. 0.7 ± 1.2 pg/ml; P < 0.05; Figure 1a ) and IL-10 (RSV: 0.89 ± 0.19 vs. 0.18 ± 0.05 pg/ml; P < 0.05), premature subjects with HPMV infection did not have significant differences in the nasal airway protein levels of CCL5/RANTES and IL-10 compared to controls (CCL5/RANTES: HMPV 0.68 ± 0.13 pg/ml vs. control 0.7 ± 0.12 pg/ml; P = 0.9; IL-10: HMPV 0.19 ± 0.24 pg/ml vs. control 0.18 ± 0.05 pg/ml; P = 0.9; Figure 1b ).
Th2/Th17 Cytokine Profile in Infants With Naturally Occurring HMPV Infection
We next investigated the natural Th2 and Th17 immune response to RSV and HMPV infections in full-term and premature individuals by measuring nasal protein levels of IL-4 and IL-17 in the same study groups. As shown in Premature children overall exhibited a less prominent increase in IFNγ/IL4 ratios during RSV or HMPV infection. Specifically, premature children with RSV infection had increase in IFNγ/ IL4 ratio but it did not reach statistical significance (RSV: 2.95, 95% CI 0.37-5.54 vs. control: 0.81 95% CI 0.65-0.97; P = 0.06; Figure 3a) . Moreover, the IFNγ/IL4 ratio in premature children infected with HMPV was essentially unchanged relative to controls (HMPV: 1.18, 95% CI 0.05-2.3 vs. control: 0.81 95% CI 0.65-0.97; P = 0.23; Figure 3b) . Collectively, these data suggest that premature children have less preponderance of antiviral Th1 response during naturally occurring RSV or HMPV infections compared to full-term children.
DISCUSSION
We studied a prospective cohort of young children aged less than or equal to 3 y to determine the association between prematurity and nasal antiviral airway cytokine responses to HMPV or RSV. To the best of our knowledge, our study is the first to demonstrate that premature infants have defective IFNγ, CCL5/RANTES, and IL-10 airway responses during HMPV infection and provides novel insights about the potential reason why HMPV causes severe respiratory disease in premature children.
Prematurity has been linked to an increased risk of severe viral respiratory infections during the first years of life (2) (3) (4) (5) . Diminished lung function may predispose prematurely born infants to severe viral respiratory illnesses (17) . Moreover, antibody-mediated immunity, which depends maternal transfer of specific IgG across the placenta, seems to be immature in premature babies (18) . In addition, T helper (Th) cytokine responses in early life are largely driven toward a Th2 phenotype leading to lower production of Th1 antiviral cytokines such as IFNγ (19) (20) (21) . This deficient cytokine production in neonates may explain the susceptibility of this age group to certain pathogens. For instance, preterm infants have deficient cytokine responses to group B streptococcus, an important cause of sepsis in newborns (22) . Complementing these findings, our study indicates that prematurity is also associated HMPV is a virus phylogenetically related to RSV that causes severe respiratory disease in premature infants (5) . Interestingly, HMPV induces an airway immune response distinct from that of RSV (12, (23) (24) (25) . In fact, the ability of HMPV-but not RSV-to ameliorate the nasal airway secretion of CCL5/ RANTES was originally reported in 2002 by Jartti et al. (8) , in one of the first articles describing HMPV infections as a cause of wheezing in children. This initial finding suggested the presence of IFN-mediated defects during HMPV infection since CCL5/RANTES expression is regulated via IFN regulatory factor 1 (IRF-1) (26) . Recent reports have confirmed that HMPV elicits weak IFN-mediated antiviral responses and consequent lower production of CCL5/RANTES and IL-10 in human peripheral blood mononuclear cells relative to RSV (12) . The latter results coincide with the reduced HMPV-induction of CCL5/RANTES and IL-10 seen in murine models (22, 23) . In agreement with these studies, we have now demonstrated that premature children infected with HMPV exhibit significantly lower levels of nasal airway IFNγ, CCL5/RANTES, and IL-10 compared to RSV-infected premature children (Figure 1a) or full-term individuals with HMPV infection (Figure 1b) . These new data indicate that HMPV is capable of attenuating IFNγ, CCL5/RANTES, and IL-10 responses in vivo and, to the best of our knowledge, is the first study to link prematurity to the previously reported defective antiviral immunity observed during HMPV infection (12) (13) (14) .
The exact reason why HMPV elicits markedly weaker IFNγ (and IL-10, CCL5) responses than RSV is still an area of active research, but there are several postulated mechanisms of defective IFN-driven antiviral immunity during HMPV infection. For instance, the structural encoding proteins of HMPV-glycoprotein G and M2-2-seem to play a critical role in modulating antiviral IFN production during HMPV infections (26) (27) (28) as demonstrated by the observation that a mutated HMPV virus lacking glycoprotein G and M2 protein induces significantly higher amounts of IFN and antiviral cytokines/chemokines than wild-type HMPV (27) . HMPV also appears to interfere with the activation of the IFN signaling cascade at different points, including Jak1, Tyk2, and IFNAR1 membrane expression (29) , all of which may lead to downstream inhibition of STAT1 and STAT2 (13, 29) . Although our study supports the concept that HMPV infection is associated with abnormal IFNγ secretion, future translational studies are needed to investigate whether the postulated HMPV-induced mechanisms of defective antiviral IFN-driven airway responses are relevant to natural HMPV infection in humans, particularly in the pediatric population.
Only few studies have investigated antiviral airway immune responses during naturally occurring HMPV and RSV infections in children. The most important limitation of pediatric studies has been the access to lung samples in this age group. To overcome this limitation, we used nasal samples, an approach used as surrogate in the evaluation of airway cytokine responses in children during naturally occurring viral respiratory infections (16, 25, 30) . Indeed, a pioneering study conducted by the INFANT foundation used this strategy to delineate the airway cytokine profile during natural viral infections in a prospective cohort of infants (25) . Similar to our current results, this study identified that subjects with HMPV had lower IFN-γ/IL-4 ratios than did those infected with RSV or influenza virus (25) , however, this study did not specifically investigate these responses in premature children. Using the same nasal washing approach, we recently identified that rhinovirus (RV) infection in early life is associated with increased nasal airway levels of the classical Th2 cytokine IL-4 (31). In our current study, we did not observe significant differences in the nasal airway secretion of IL-4 or the Th17 cytokine IL-17 in children with naturally occurring RSV or HMPV infection (Figure 2) . These data highlight the prevailing notion that airway cytokine profiles are influenced by host-and viral-specific factors (32) . For instance, pediatric hosts with wheeze and/or atopy have a differential antiviral cytokine profile influenced by the infecting virus (32) . Our study suggests that in the case of the premature host infected with HMPV, the predominant immune profile is an attenuated airway secretion of IFNγ, CCL5/RANTES, and IL-10, which might underlie the severity of HMPV in this group of children.
Limitations of the present study include the lack of information on clinical data (i.e., severity scores, outcomes) and viral load, which we recognize would be important to establish the clinical relevance of the different cytokine profiles among premature and full-term groups. In addition, given the crosssectional design of our study we do not have comparisons of baseline vs. viral induces cytokines, thus the results from this study could also be interpreted as premature infant responses being consistent with previous reports in the literature and the full-term infant responses as being abnormally exuberant. Accordingly, longitudinal studies that correlate baseline and viral-induced cytokines levels with disease relevant markers (hospitalization rates, severity scores) are still required to confirm our findings and to establish the clinical significance of the results presented. Future studies should also investigate if children born late preterm (32 to <37 wk gestation) exhibit impaired airway antiviral IFNγ responses to RSV and or HMPV. This is an important issue because of changing RSV prophylaxis recommendations for the older preterm infants (11) .
Conclusion
In summary, in this cross sectional study, premature infants exhibited defective IFNγ, CCL5/RANTES, and IL-10 airway responses during HMPV infection. These new data support the previously described HMPV-induced defective IFN antiviral immunity in human-based cellular and animal models (12) (13) (14) , as well as in the nasal airway secretions of infants with naturally occurring viral infections (27) , and provide new insights about the potential underlying reason why HMPV causes severe respiratory disease in young individuals with history of prematurity.
